Gene patents may hamper innovations in patient care

[kar.san...@gmail.com]

Gene patents are discoveries, not inventions and patenting discoveries may hamper future innovations in developing cost-effective patient care products and services. Scientific and technological innovations in molecular cloning, sequencing, PCR, bioinformatics, biochemical methods etc., have created innovative ways to identify genes and assign functions, without these inventions genes would have been a still unknown factor. Thus, gene patents are not true inventions; rather these are discoveries made possible through other technological and scientific inventions. Banning gene patents may offer incredible opportunities for innovations that can attract investments to create sustainable entrepreneurial establishments and scientific jobs, which may be significantly higher that gene patents alone can offer. In contrast, granting gene patents may lead to innovation bottlenecks that favor fewer inventions, restricted entrepreneurial initiatives, limited job growth, and non-competitive monopoly. The original blog can be viewed at: http://www.sciclips.com/sciclips/blogArticle.do?id=1025&blog=Gene%20patents%20may%20hamper%20innovations%20in%20patient%20care